In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions
- PMID: 15849177
- DOI: 10.1634/stemcells.2004-0183
In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions
Abstract
Fibroblasts, which are widely distributed and play a key part in tissue fibrosis, are phenotypically and functionally heterogeneous. Recent studies reported that bone marrow can be a source of tissue fibroblast. In the study reported here, we investigated in vivo characterization of bone marrow-derived fibroblasts recruited into various fibrotic lesions. Mice were engrafted with bone marrow isolated from transgenic mice expressing green fluorescent protein (GFP), and fibrotic lesions were induced by cancer implantation (skin), excisional wounding (skin), and bleomycin administration (lung). A small population of GFP+ fibroblast was found even in nonfibrotic skin (8.7% +/- 4.6%) and lung (8.9% +/- 2.5%). The proportion of GFP+ fibroblasts was significantly increased after cancer implantation(59.7% +/- 16.3%) and excisional wounding (32.2% +/- 4.8%), whereas it was not elevated after bleomycin administration (7.1% +/- 2.4%). Almost all GFP+ fibroblasts in fibrotic lesions expressed type I collagen, suggesting that bone marrow-derived fibroblasts would contribute to tissue fibrosis. GFP+ fibroblasts expressed CD45, Thy-1, and alpha-smooth muscle actin at various proportions. Our results suggested that bone marrow-derived fibroblasts expressed several fibroblastic markers in vivo and could be efficiently recruited into fibrotic lesions in response to injurious stimuli; however, the degree of recruitment frequency might depend on the tissue microenvironment.
Similar articles
-
Parabiosis and transplantation models show no evidence of circulating dermal fibroblast progenitors in bleomycin-induced skin fibrosis.J Cell Physiol. 2008 Jan;214(1):230-7. doi: 10.1002/jcp.21182. J Cell Physiol. 2008. PMID: 17579342
-
Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells.J Cell Physiol. 2010 Mar;222(3):703-12. doi: 10.1002/jcp.21997. J Cell Physiol. 2010. PMID: 20020505
-
Intracardiac fibroblasts, but not bone marrow derived cells, are the origin of myofibroblasts in myocardial infarct repair.Cardiovasc Pathol. 2005 Sep-Oct;14(5):241-6. doi: 10.1016/j.carpath.2005.05.004. Cardiovasc Pathol. 2005. PMID: 16168896
-
The bone marrow leaves its scar: new concepts in pulmonary fibrosis.J Clin Invest. 2004 Jan;113(2):180-2. doi: 10.1172/JCI20782. J Clin Invest. 2004. PMID: 14722608 Free PMC article. Review.
-
The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond.Proc Am Thorac Soc. 2006 Jun;3(4):373-6. doi: 10.1513/pats.200512-133TK. Proc Am Thorac Soc. 2006. PMID: 16738203 Free PMC article. Review.
Cited by
-
Skin wound healing modulation by macrophages.Int J Clin Exp Pathol. 2010 Jul 25;3(7):643-53. Int J Clin Exp Pathol. 2010. PMID: 20830235 Free PMC article. Review.
-
The Blood Circulating Rare Cell Population. What is it and What is it Good For?Cells. 2020 Mar 25;9(4):790. doi: 10.3390/cells9040790. Cells. 2020. PMID: 32218149 Free PMC article. Review.
-
Cell therapy in dermatology.Cold Spring Harb Perspect Med. 2014 Jun 2;4(6):a015156. doi: 10.1101/cshperspect.a015156. Cold Spring Harb Perspect Med. 2014. PMID: 24890834 Free PMC article. Review.
-
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.J Cell Mol Med. 2006 Jan-Mar;10(1):76-99. doi: 10.1111/j.1582-4934.2006.tb00292.x. J Cell Mol Med. 2006. PMID: 16563223 Free PMC article. Review.
-
Cellular and molecular mechanisms of intestinal fibrosis.World J Gastroenterol. 2012 Jul 28;18(28):3635-61. doi: 10.3748/wjg.v18.i28.3635. World J Gastroenterol. 2012. PMID: 22851857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous